Skip to main content

Table 7 Characteristics and clinical parameters of PTX3 genotypes

From: Association between PTX3 and PVT1 genetic polymorphisms and the risk of diabetic kidney disease in type 2 diabetic patients

Clinical characteristics

AA

AG+GG

P value

Number

161

119

-

Age (years)

55.2 ± 0.62

55.8 ± 0.34

0.15

Gender (male/female)

86/101

59/78

0.60

BMI (Kg/m2)

24.1 ± 0.94

24.08 ± 0.75

0.98

Diabetes duration (years)

15 ± 0.66

15.8 ± 0.71

0.01*

Fasting blood glucose (mg/dL)

136.7 ± 0.78

140.9 ± 2.08

0.01*

Post prandial glucose (mg/dL)

122.5 ± 1.03

124.7 ± 0.98

< 0.001*

HbA1c (%)

7.1 ± 1.4

8.9 ± 0.21

< 0.001*

Serum creatinine (mg/dL)

75.9 ± 0.94

76.2 ± 1.3

0.10

eGFR (ml/min)

74.8 ± 0.94

75.3 ± 0.55

0.10

Protein to creatinine ratio (mg/g)

47.1 ± 2.6

59.2 ± 1.2

< 0.001*

Smoking

78

84

0.48

Systolic blood pressure (mmHg)

116 ± 0.8

122.1 ± 0.50

< 0.001*

Diastolic blood pressure (mmHg)

76.2 ± 0.44

77.3 ± 0.85

0.009*

  1. Data are n, means ± S.E.M.
  2. BMI body mass index, HbA1c glycosylated haemoglobin, PTX3 pentraxin 3, eGFR estimated glomerular filtration rate, NS non-significant
  3. *p < 0.05